Established 20032012 Gastrointestinal Oncology Conference Review |
2012 Gastrointestinal Oncology Conference Please click on abstract title to review abstract PDF file (opens in a new window). |
| Esophageal Cancer |
| Chemotherapy Alone is an Appropriate Preoperative Therapy for Locally Advanced Esophageal Cancer Hope E. Uronis Duke University Medical Center, Durham, NC |
| Chemotherapy and Radiotherapy are Necessary Preoperative Therapy David H. Ilson Memorial Sloan-Kettering Cancer Center, New York, NY |
| CT-Based Assessment of Visceral Adiposity and Outcomes for Esophageal Adenocarcinoma Saeed NA Moffitt Cancer Center, Department of Gastrointestinal Oncology |
| Phase II Trial of Sorafenib in Esophageal (E) and Gastroesophageal Junction (GEJ) Cancer: Response Observed in Adenocarcinoma E. Won Memorial Sloan-Kettering Cancer Center, New York, NY |
| Pancreatic Cancer |
| Borderline Resectable Pancreatic Cancer Jason B. Fleming MD Anderson Cancer Center, Houston, TX |
Mast cells in tumor microenvironment promotes the in vivo growth of pancreatic ductal adenocarcinoma. |
| Advanced Colorectal Cancer |
| Use of Anti-EGFR Antibodies in First-Line Therapy of Metastatic CRC Howard S. Hochster Professor of Medicine, Yale Cancer Center, New Haven, CT |
| Asian Approach to Advanced Colorectal Cancer (First-Line) Kohei Shitara National Cancer Center Hospital East, Chiba, Japan |
| Maintenance Therapy With Biologics Johanna Bendell Sarah Cannon Research Institute, Nashville, Tennessee |
| Aflibercept vs Placebo in Combination With FOLFIRI After Failure of an Oxaliplatin-Based Regimen for Metastatic Colorectal Cancer: North American Results of a Multinational Phase III Trial (EFC10262-VELOUR) Edith P. Mitchell |
| Hot Topics in Gastrointestinal Oncology |
| Inflammation and Gastric Caner: Helicobacter pylori Juanita L. Merchant University of Michigan, Ann Arbor, Michigan |
| Neuroendocrine Tumors (NET) |
| Molecular Markers, Molecular Signatures and Treatment Decision in Stage II Colon Cancer Daniel Sargent Mayo Clinic, Rochester, MN |
| Japanese Perspectives on Adjuvant Chemotherapy for Colorectal Cancer Nozomu Fuse National Cancer Center Hospital East, Kashiwashi, Chiba, Japan |
| New therapeutic possibilities of combined treatment of radiotherapy with cisplatin, oxaliplatin or their liposomal formulations (Lipoplatin and Lipoxal) in colorectal cancer using nude mouse xenograft Thititip Tippayamontria Department of Nuclear Medicine and Radiobiology |
| Hepatobiliary Cancer |
| Update on the Pathologic Classification and Grading of NETs David S. Klimstra Memorial Sloan-Kettering Cancer Center, New York, New York |
| POSTER PRESENTATIONS |
| Esophageal/Gastric Cancer |
| Esophageal Cancer: A Study on an Unusual Case of Recurrence Occurring Five Years After Initial Chemo-Radiation Therapy and Related Literature Review Hong Chin, Reba Cowell Dayton VA Medical Center, Dayton, OH |
| Relationship between Late Radiotherapy toxicity after pelvic cancers Bhavna Gami The GI Unit |
| Autologous Cell Therapy with Induced Pluripotent Stem Cells (iPSCs) Encoded with Anti-GRP78 shRNA Induces Apoptosis After a Gene-Silencing Bystander Effect Circumventing Angiogenesis, and Metastatic Spread in Advanced Gastrointestinal Stromal Tumors (GIST) John N Giannios Univ of Varna, International Society of Molecular and Genomic Medicine |
| Salvage Gastrectomy After Intravenous and Intraperitoneal Paclitaxel Combined with Oral S-1 for Gastric Cancer with Peritoneal Metastasis Joji Kitayama, Hironori Ishigami, Hironori Yamaguchi, Shigenobu Emoto, Toshiaki Watanabe University of Tokyo, Tokyo, Japan |
| Audit Attempting to Identify Factors Which May Predict Failed Resection of Oesophago-Gastric Cancer Operations Emilie Nicholls ZT (NHS Lancashire Teaching Trust), EN (NHS Lancashire Teaching Trust), PT (NHS Lancashire Teaching Trust), KGP (NHS Lancashire Teaching Trust), JBW (NHS Lancashire Teaching Trust) |
| Pancreatic Cancer |
| A Pilot Phase II Trial of Cetuximab, Gemcitabine, 5-Fluorouracil and Radiation Therapy in Locally Advanced Non-Metastatic Pancreatic Adenocarcinoma Cetin V UMass Memorial Medical Center, Worcester, Massachusetts |
| Pathophysiology of Pancreatic Cancer in Patients over 80 Years of Age Cuervo L, Song J, Ashley P, Wajima T, Wong L Scott & White Healthcare/Texas A&M University Health Science Center, Temple, Texas, USA. |
| Recurrent Pulmonary Embolism Resulting in Sudden Death as the Presenting Symptom of Periampullary Duodenal Adenocarcinoma Basile Njei, Harold Sanchez University of Connecticut, Farmington, CT |
| Advanced Colon Cancer |
| Epigenomic Treatment with LNA-Modified Oligonucleotides Targeting mRNA of DICER via PEG-Nanosomes with Linked Abs Against CD44 on Cancer Stem Cells (CSCs) and Metastatic Colorectal Ca (mCRC) Induces PCD Type-I and a Bystander Killing Effect (BKE) After Dual Inhibition of Epigenetic Oncomirs Which Interferes with Genomic Pathways that Downregulate Antiapoptotic Coding and Noncoding Oncogenes by Interacting with Their 3'UTRs, and Demethylation of CpG Islands Leading to Activation of Apoptotic Tumor Suppressor Nnonprotein Coding Genes and miRNAs J. Giannios, K. Ivanov, K. Metodiev Dept of Translational Medicine, Medical University of Varna, EU |
Efficacy and Safety of Regorafenib in Previously Treated Metastatic Colorectal Cancer (mCRC) – Results of the Randomized, Placebo-Controlled, Phase 3 CORRECT Trial |
| The Value of Tumor M2-Pyruvate Kinase in Stomach Cancer Screening Dae Young Cheung, Jung Ho Kim, Tae Ho Kim, Sung Soo Kim, Jin Il Kim, Jae Kwang Kim Department of Internal Medicine, the Catholic University of Korea College of Medicine, Seoul, Korea |
| The Role of Perfusion Computed Tomography in Assessment of Spatial and Temporal Vascular Heterogeneity in Rectal Cancers Aftab Khan Department of Gastrointestinal Research, Mount Vernon Cancer Treatment and Research Centre, Northwood, Greater London, UK |
| Combined Fecal Transferrin Test and Immuno Fecal Occult Blood Test for Detecting Colorectal Cancer and Advanced Adenoma in Asymptomatic and Symptomatic Populations Peng Jin Department of Gastroenterology, Beijing Military General Hospital, Beijing, People’s Republic of China |
| Above-label doses of octreotide-LAR in patients with metastatic small intestinal carcinoid tumors Jonathan Strosberg, Jill Weber, Max Feldman, Larry Kvols H. Lee Moffitt Cancer Center, 12902 Magnolia Dr. Tampa FL |
| Long-term, Open-label Everolimus in Patients With Pancreatic Neuroendocrine Tumors: Two Case Presentations From RADIANT-3 Edward M. Wolin Samuel Oschin Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA |
| ©2022 International Society of Gastrointestinal Oncology | info@isgio.org |